Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Millet Seed Extract in the Treatment of Telogen Effluvium in Female Patients: A Randomized, Double-Blind, Controlled Trial

NCT07348120 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT07348120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07348120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Millet Seed Extract in the Treatment of Telogen Effluvium in Female Patients: A Randomized, Double-Blind, Controlled Trial
Lead sponsor
Kasr El Aini Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2025
Completion date
March 1, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

telogen effluvium